SIHS 2011-13 GE/PI call getters

thanks a lot amneet singh for guiding us..
puys, recently sanofi aventis and genzyme deal is hot issue shall we start discussion this topic?


I think first discuss the Piramal health care acquired by Abbot as its a deal which is already completed and have majot impact on Indian pharma sector.
The genzyme sanofi deal you can discuss later as it has less impact on Indian Pharma Sector.
ATB.

Abbott has completed its acquisition of Piramal's Healthcare Solutions business, propelling it to market leadership in the Indian pharmaceutical market and further accelerating the company's growth in emerging markets.

Throughout the past decade, Abbott has established a leading presence in emerging markets - today, more than 20 percent of the company's total sales are generated in these growing economies.

"The acquisition of Piramal's Healthcare Solutions business further strengthens Abbott's growing presence in emerging markets," said Miles D. White, chairman and chief executive officer, Abbott. "Piramal's portfolio of well-known, trusted products has served patients in India for decades. Combined with existing product offerings, Abbott is uniquely positioned to meet the needs of one of the world's fastest-growing pharmaceutical markets."

India's rapid pharmaceutical market growth is being driven largely by branded generics. The market will generate nearly $8 billion in pharmaceutical sales this year, a number that is expected to more than double by 2015. Abbott expects its pharmaceutical sales in India to exceed $2.5 billion by 2020.

Piramal's Healthcare Solutions business has a comprehensive portfolio of branded generics, including market-leading brands in multiple therapeutic areas, including antibiotics, respiratory, cardiovascular, pain and neuroscience.

The Healthcare Solutions business will operate as a separate business unit, reporting into Abbott's newly-created Established Products Division (EPD), which was formed to focus on branded generics, maximizing the opportunity in emerging markets. The business will continue to be led by its current India-based management team.

"Piramal's proven business model in India and experienced local leadership team, combined with the global resources of Abbott, will allow us to build upon Piramal's commitment to quality and service," said Michael J. Warmuth, senior vice president, Established Products, Pharmaceutical Products Group, Abbott.

Abbott now employs approximately 10,000 people across all of its businesses in India.

Abbott, through a wholly-owned subsidiary, purchased the assets of Piramal's Healthcare Solutions business for a $2.2 billion up-front payment with additional payments of $400 million annually for the next four years, beginning in 2011. This transaction will not impact Abbott's ongoing earnings per share guidance in 2010

if someone could enumerate some of the famous brand names of piramal products and abbott products

hiiiiiiiiii!!!! how many attested docments we have to bring /original doc???:lookround:

chkishore25 Says
if someone could enumerate some of the famous brand names of piramal products and abbott products


About Abbott
Abbott (NYSE: ABT) is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

Piramal Products:
1. Prescribers Product List
2. Abbott Healthcare Pvt Ltd Products | Textbook Brands
3. Abbott Healthcare Pvt Ltd | Products Power Brands
MikeyJ Says
hiiiiiiiiii!!!! how many attested docments we have to bring /original doc???:lookround:


1 set only:cheerio:

some more points are-
As part of its strategy to move beyond the proprietary or patented drugs business, Abbott recently set up the Established Product Business globally. The business is spearheading the pharma giants penetration into emerging market regions. This is the second acquisition for the company over the past year and follows the $6.2-billion deal for the branded generics portfolio of Solvay Pharmaceuticals, which gave it access to the European market. The deal gave the company control of Solvays Indian business and added a fifth to its consolidated sales of about Rs 1,000 crore.

Abbot is also utilising its presence in the country by outsourcing drug manufacturing and marketing it though its centres worldwide. Recently, it entered into a licensing agreement with Zydus Cadila to market 24 products in 15 emerging markets, with an option to add another 40. Its India focus can also be gauged by the fact that the company had agreed to buy Wockhardts nutrition business for Rs 620 crore before legal problems stalled this

next topic i would suggest "medical tourism in india"

Medical tourism of India is opening its feathers to fly high.


Equipped with the cutting edge technology, the health care sector in India has geared up its speed to be one of the most flourishing industries. The privatization of the healthcare sector has carried with it excellent facilities, brilliant improvement in infrastructure and world-class treatments.


Offering an array of superb quality hospitals and treatments at very low cost, now India proves itself to be one of the best places for the medical treatment in the world. To add on, India is one of the largest pharmaceutical industries in the world. It is self sufficient in drug production and exports drugs to more than 180 countries.


Indian hospitals are becoming known internationally for standards of health care delivery, success rates and service levels. India has the technology and the skilled super specialists along with outstanding infrastructure and professional management, nurses and paramedical staff to take on international competition.


Every year thousand of visitors are coming to India from around the world just for the medical check up and various type of surgery. Variety of treatments is available in India like Cardiac Surgery, Bone Mone marrow transplant, Liver transplant, Orthopaedic surgery etc. Many people from the developed world come to India for the rejuvenation promised by yoga and Ayurvedic massage. Cost of key health care treatment is upto 30% low and cheapest in entire Southeast Asia.


The medical tourism market in India has been expected to grow to around Rs 11, 000 CR by the next couple of years approx till 2012-13.

Dear Rahim

The topics for our GD last year were quite relevant to the current the healthcare scenario. Like the topic that my group got was 'Is it the architecture or the spectrum of services provided by the hospital that make a hospital preferable choice over other hospital" , etc. Please keep yourself updated with the latest happenings in the Indian/International healthcare sector (you can search internet, read business newspapers, etc). There's a lot happening these days in the pharmaceutical sector( Mergers & Acquisitions) , so I would personally suggest to have a good grasp on those.

Apart from the GD, the essay topics were pretty general, like "Is the Indian population a boon or a bane for the Indian Economic Health. Cant say anything about this years expected topics, so be ready for everything.

All the best for your GE/PI.
:cheerio:
P.S.: you can drop in your queries at [email protected] for any further help. I'll be more than happy to answer to as many as possible. :

Thanks and Regards
Amneet Singh Bedi
MBA HHC
2010-12 batch



amneet singh please reply of my mail

----------------------------------------------------

buddy remove the email id. Its against PG rules,

Second thing is,
I had applied last year aand in out group there were two topics, one was General and the other Health care specific. So I think people should practice both the type.
Just an opinion.

hey Khanjan
thanks for correcting me.
To all the prospects,
Last year we had 2 topics in a time frame of 30-40 minutes in total.
One topic related to healthcare and the second one on a current affair/general topic around 15-20 minutes for each. Again, I am not promising that it will be the same this year; the process may/ may not change. Keep your eyes and ears open and be ready for anything.

Thanks and regards
Amneet Singh Bedi
hey Khanjan
thanks for correcting me.
To all the prospects,
Last year we had 2 topics in a time frame of 30-40 minutes in total.
One topic related to healthcare and other one a current affair/general.
Again, I would suggest you all to be ready for anything.

Thanks and regards
Amneet Singh Bedi


Amneet sir,
i am pharma graduate and i have 1 yr work ex in pharma mktng
what kind of job profile can i get after MBA HHC?
what is the range of package the company is offering and please give few pharma companies whch come for placement.
Amneet sir,
i am pharma graduate and i have 1 yr work ex in pharma mktng
what kind of job profile can i get after MBA HHC?
what is the range of package the company is offering and please give few pharma companies whch come for placement.

Hi Rahim
Regarding your query of job profile, I've referred your query to the students in our batch who hail from the pharma background, you can expect a reply soon from them. I'll post the same here as well for the benefit of others as soon as i get the reply.

Please refer to the website www.sihspune.org for the details like placement packages and companies that come for placements. You can even download the summer internship brochure from the website and have a look at the companies for summer placements as well.

hey..
can anyone tell..
is there any need to carry the originals with us,or the photo copy of mark sheets will do?

hey..
can anyone tell..
is there any need to carry the originals with us,or the photo copy of mark sheets will do?


we have to carry the originals alongwith the photocopies
hey Khanjan
thanks for correcting me.
To all the prospects,
Last year we had 2 topics in a time frame of 30-40 minutes in total.
One topic related to healthcare and the second one on a current affair/general topic around 15-20 minutes for each. Again, I am not promising that it will be the same this year; the process may/ may not change. Keep your eyes and ears open and be ready for anything.

Thanks and regards
Amneet Singh Bedi


Well this yr they have a separate 15 mks section for case analysis...so can we still expect two gd topics as last year..or was it there last yr as well ???

below are a few limks which would be helpful for interview perpective

SC enters surrogacy debate, asks if an Indian baby is a 'commodity'
Social and ethical basis of legislation on surrogacy: need for debate
Surrogate Mothers in India - Outsourcing Surrogacy to India - surogate mother - Marie Claire
Surrogacy in India - Low Cost Indian Surrogacy
http://www.whoindia.org/LinkFiles/Commision_on_Macroeconomic_and_Health_Primary_Health_Care_in_India_Review_of_Policy_Plan_and_Committee_Reports.pdf
http://www.pwc.com/en_GX/gx/healthcare/pdf/emerging-market-report-hc-in-india.pdf
Medical Tourism - Medical Tourism In India, Medical Tourism Hospitals

planningcommission.nic.in/reports/genrep/.../26_bg2020.doc
:thumbsup:

hey can any1 tell me frm where to get sihs online application form.. I dint take out its printout then..

Online Registration - SIHS
seema yadav Says
hey can any1 tell me frm where to get sihs online application form.. I dint take out its printout then..